Isaka Y - Search Results

1

Cigarette smoking and chronic kidney diseases.

Nagasawa Y, Yamamoto R, Rakugi H, Isaka Y. Nagasawa Y, et al. Among authors: isaka y. Hypertens Res. 2012 Mar;35(3):261-5. doi: 10.1038/hr.2011.205. Epub 2011 Dec 8. Hypertens Res. 2012. PMID: 22158113 Review.

2

Gene therapy in renal diseases.

Imai E, Takabatake Y, Mizui M, Isaka Y. Imai E, et al. Among authors: isaka y. Kidney Int. 2004 May;65(5):1551-5. doi: 10.1111/j.1523-1755.2004.05409.x. Kidney Int. 2004. PMID: 15086890 Free article. Review.

3

Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney disease.

Hamano T, Fujii N, Nagasawa Y, Isaka Y, Moriyama T, Okada N, Imai E, Horio M, Ito T. Hamano T, et al. Among authors: isaka y. Bone. 2006 Nov;39(5):1067-1072. doi: 10.1016/j.bone.2006.04.022. Epub 2006 Jun 16. Bone. 2006. PMID: 16781904

4

Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD).

Fujii N, Hamano T, Mikami S, Nagasawa Y, Isaka Y, Moriyama T, Horio M, Imai E, Hori M, Ito T. Fujii N, et al. Among authors: isaka y. Nephrol Dial Transplant. 2007 Jun;22(6):1601-7. doi: 10.1093/ndt/gfl567. Epub 2006 Nov 23. Nephrol Dial Transplant. 2007. PMID: 17124283 Clinical Trial.

5

Pharmacokinetics of olmesartan medoxomil in hemodialysis patients: little effect of dialysis upon its pharmacokinetics.

Tanaka H, Nagasawa Y, Matsui I, Hamano T, Iwatani H, Kawada N, Horio M, Ito T, Isaka Y, Imai E. Tanaka H, et al. Among authors: isaka y. Clin Exp Nephrol. 2009 Feb;13(1):61-5. doi: 10.1007/s10157-008-0067-0. Epub 2008 Jun 24. Clin Exp Nephrol. 2009. PMID: 18574553 Clinical Trial.

6

Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients.

Mikami S, Hamano T, Fujii N, Nagasawa Y, Isaka Y, Moriyama T, Matsuhisa M, Ito T, Imai E, Hori M. Mikami S, et al. Among authors: isaka y. Hypertens Res. 2008 Jun;31(6):1163-70. doi: 10.1291/hypres.31.1163. Hypertens Res. 2008. PMID: 18716364

7

Valvular injury in a patient with PR3-ANCA-associated glomerulonephritis.

Iwatani H, Nagasawa Y, Oka K, Isaka Y, Imai E. Iwatani H, et al. Among authors: isaka y. Nat Clin Pract Nephrol. 2008 Oct;4(10):576-82. doi: 10.1038/ncpneph0943. Epub 2008 Sep 2. Nat Clin Pract Nephrol. 2008. PMID: 18762796

8

Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.

Tomida K, Hamano T, Mikami S, Fujii N, Okada N, Matsui I, Nagasawa Y, Moriyama T, Ito T, Imai E, Isaka Y, Rakugi H. Tomida K, et al. Among authors: isaka y. Bone. 2009 Apr;44(4):678-83. doi: 10.1016/j.bone.2008.11.016. Epub 2008 Dec 9. Bone. 2009. PMID: 19111635

9

Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure.

Matsui I, Hamano T, Mikami S, Fujii N, Takabatake Y, Nagasawa Y, Kawada N, Ito T, Rakugi H, Imai E, Isaka Y. Matsui I, et al. Among authors: isaka y. Kidney Int. 2009 May;75(9):915-28. doi: 10.1038/ki.2008.700. Epub 2009 Feb 4. Kidney Int. 2009. PMID: 19190677 Free article.

10

Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats.

Matsui I, Hamano T, Tomida K, Inoue K, Takabatake Y, Nagasawa Y, Kawada N, Ito T, Kawachi H, Rakugi H, Imai E, Isaka Y. Matsui I, et al. Among authors: isaka y. Nephrol Dial Transplant. 2009 Aug;24(8):2354-61. doi: 10.1093/ndt/gfp117. Epub 2009 Mar 18. Nephrol Dial Transplant. 2009. PMID: 19297354

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

561 results

Search Page

Filters